Ribbon Acquisition Corp.

RIBBR
$0.20 (- $0.03 - 13.91%)
Last updated: 2026-05-21 16:13 UTC
RIBBR Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
Sector N/A
Industry N/A
ISINN/A
Market Price0.2
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPSN/A
Market CapN/A
Book Value-0.05
Price to Book-3.321
Beta1.74
52w High0.2
52w Low0.18
Next Earnings DateN/A

Ribbon Acquisition Corp. trades under ticker RIBBR on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. Also searched as Ribbon Acquisition.

Related researchRIBBR stock priceRIBBR share priceRibbon Acquisition stockRibbon Acquisition share price
About the Company
Ribbon Acquisition Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), incorporated in the Cayman Islands as an exempted company with limited liability. Its primary purpose is to effectuate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company raised $50 million in its initial public offering, with each unit comprising a Class A ordinary share and a right to receive a fraction of a Class A ordinary share upon the completion of its first business combination. Ribbon Acquisition Corp. does not engage in commercial operations, generate revenue, or carry out substantive business activities until it completes a qualifying transaction. As a SPAC, it plays a notable role in the financial markets by providing an alternative route for private companies to become publicly traded, often streamlining the process compared to traditional initial public offerings and offering flexibility for both target companies and investors.
Price History
Latest News for RIBBR
DRC Medicine Ltd. Announces the Business Combination Agreement with Ribbon Acquisition Corp.
Combined Company Expected to be Listed on NASDAQ Global Market DRC Medicine Ltd. (“DRC Medicine” or the “Company”), is an innovative healthcare and biotechnology company headquartered in Japan, focused on the research, development, and commercialization of advanced medical technologies that address significant global health challenges. The Company is best known for its proprietary Hydro Silver Titanium® technology, initially applied in consumer hygiene products such as masks and towels, and now